These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29772941)

  • 1. Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections.
    Du K; Liu J; Broering R; Zhang X; Yang D; Dittmer U; Lu M
    Expert Opin Drug Discov; 2018 Jul; 13(7):661-670. PubMed ID: 29772941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.
    Zhang X; Kraft A; Broering R; Schlaak JF; Dittmer U; Lu M
    Expert Opin Drug Discov; 2012 Jul; 7(7):597-611. PubMed ID: 22607384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.
    Lucifora J; Bonnin M; Aillot L; Fusil F; Maadadi S; Dimier L; Michelet M; Floriot O; Ollivier A; Rivoire M; Ait-Goughoulte M; Daffis S; Fletcher SP; Salvetti A; Cosset FL; Zoulim F; Durantel D
    Sci Rep; 2018 Mar; 8(1):5390. PubMed ID: 29599452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antivirals for the treatment of chronic hepatitis B.
    Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
    Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
    Pei Y; Wang C; Yan SF; Liu G
    J Med Chem; 2017 Aug; 60(15):6461-6479. PubMed ID: 28383274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
    Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
    Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.
    Soriano V; de Mendoza C; Peña JM; Barreiro P
    Expert Opin Pharmacother; 2015 Feb; 16(2):179-86. PubMed ID: 25529507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status and future directions of hepatitis B antiviral drug discovery.
    Tang L; Zhao Q; Wu S; Cheng J; Chang J; Guo JT
    Expert Opin Drug Discov; 2017 Jan; 12(1):5-15. PubMed ID: 27797587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview.
    Kayesh MEH; Kohara M; Tsukiyama-Kohara K
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.
    Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M
    Front Immunol; 2022; 13():965018. PubMed ID: 35967443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The course and treatment of chronic hepatitis B in HIV-infected patients].
    Maksimov SL; Tsarenko SP; Kravchenko AV; Iushchuk ND
    Ter Arkh; 2010; 82(11):32-7. PubMed ID: 21381346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.
    Soleiman-Meigooni S; Yarahmadi A; Kheirkhah AH; Afkhami H
    Front Immunol; 2024; 15():1363996. PubMed ID: 38545106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
    Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
    AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
    Boni C; Vecchi A; Rossi M; Laccabue D; Giuberti T; Alfieri A; Lampertico P; Grossi G; Facchetti F; Brunetto MR; Coco B; Cavallone D; Mangia A; Santoro R; Piazzolla V; Lau A; Gaggar A; Subramanian GM; Ferrari C
    Gastroenterology; 2018 May; 154(6):1764-1777.e7. PubMed ID: 29378197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and treatment of chronic hepatitis B in HIV-positive patients.
    Soriano V; de Mendoza C; Fernández-Montero JV; Labarga P; Barreiro P
    Ann Med; 2014 Aug; 46(5):290-6. PubMed ID: 24716736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
    Isogawa M; Robek MD; Furuichi Y; Chisari FV
    J Virol; 2005 Jun; 79(11):7269-72. PubMed ID: 15890966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging pipeline drugs for hepatitis B infection.
    Cox N; Tillmann H
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):713-29. PubMed ID: 22195605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.